CLINICAL_TRIALS
trial_result
· 2015-04-14
Clinical Trial Update: Pegasys in Patients With Chronic Myeloid Leukemia (CML) [Phase 2]
Summary
A Phase 2 clinical trial evaluating Pegasys (pegylated interferon alfa-2a) in chronic myeloid leukemia was terminated, with results posted in April 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2015-04-14